| 000 | 01665 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513231937.0 | ||
| 264 | 0 | _c20010510 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/s0960-894x(00)00644-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevin, J I | |
| 245 | 0 | 0 |
_aHeteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJan 2001 |
||
| 300 |
_a239-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCombinatorial Chemistry Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xchemical synthesis |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aMatrix Metalloproteinase 13 |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSulfonamides _xchemical synthesis |
| 650 | 0 | 4 |
_aortho-Aminobenzoates _xchemical synthesis |
| 700 | 1 | _aGu, Y | |
| 700 | 1 | _aNelson, F C | |
| 700 | 1 | _aZask, A | |
| 700 | 1 | _aDiJoseph, J F | |
| 700 | 1 | _aSharr, M A | |
| 700 | 1 | _aSung, A | |
| 700 | 1 | _aJin, G | |
| 700 | 1 | _aCowling, R | |
| 700 | 1 | _aChanda, P | |
| 700 | 1 | _aCosmi, S | |
| 700 | 1 | _aHsiao, C L | |
| 700 | 1 | _aEdris, W | |
| 700 | 1 | _aWilhelm, J | |
| 700 | 1 | _aKillar, L M | |
| 700 | 1 | _aSkotnicki, J S | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 11 _gno. 2 _gp. 239-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(00)00644-2 _zAvailable from publisher's website |
| 999 |
_c11144485 _d11144485 |
||